278 related articles for article (PubMed ID: 30513378)
1. Impact of Smoking on Outcomes of HPV-related Oropharyngeal Cancer Treated with Primary Radiation or Surgery.
Vawda N; Banerjee RN; Debenham BJ
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1125-1131. PubMed ID: 30513378
[TBL] [Abstract][Full Text] [Related]
2. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
Broughman JR; Xiong DD; Moeller BJ; Contrera KJ; Prendes BL; Lamarre ED; Ku JA; Burkey BB; Woody NM; Joshi NP; Adelstein DJ; Geiger JL; Frenkel CH; Milas ZL; Brickman DS; Sumrall AL; Carrizosa DR; Greskovich JF; Koyfman SA; Ward MC
Cancer; 2020 Jun; 126(12):2784-2790. PubMed ID: 32167593
[TBL] [Abstract][Full Text] [Related]
5. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.
Granata R; Miceli R; Orlandi E; Perrone F; Cortelazzi B; Franceschini M; Locati LD; Bossi P; Bergamini C; Mirabile A; Mariani L; Olmi P; Scaramellini G; Potepan P; Quattrone P; Ang KK; Licitra L
Ann Oncol; 2012 Jul; 23(7):1832-7. PubMed ID: 22115925
[TBL] [Abstract][Full Text] [Related]
6. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
[TBL] [Abstract][Full Text] [Related]
7. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P
Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290
[TBL] [Abstract][Full Text] [Related]
8. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
[TBL] [Abstract][Full Text] [Related]
9. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes.
Chen SY; Last A; Ettyreddy A; Kallogjeri D; Wahle B; Chidambaram S; Mazul A; Thorstad W; Jackson RS; Zevallos JP; Pipkorn P
Am J Otolaryngol; 2021; 42(3):102915. PubMed ID: 33482566
[TBL] [Abstract][Full Text] [Related]
10. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
[TBL] [Abstract][Full Text] [Related]
11. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
Bossi P; Orlandi E; Miceli R; Perrone F; Guzzo M; Mariani L; Granata R; Locati L; Fallai C; Cortelazzi B; Pilotti S; Scaramellini G; Gloghini A; Licitra L
Ann Oncol; 2014 Mar; 25(3):694-699. PubMed ID: 24510315
[TBL] [Abstract][Full Text] [Related]
13. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
14. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
15. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review.
Chen SY; Massa S; Mazul AL; Kallogjeri D; Yaeger L; Jackson RS; Zevallos J; Pipkorn P
Am J Otolaryngol; 2020; 41(5):102592. PubMed ID: 32521295
[TBL] [Abstract][Full Text] [Related]
16. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Alfaraj F; Craig T; Huang SH; O'Sullivan B; Su J; Bayley A; Bratman S; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Hansen A; de Almeida J; Perez-Ordonez B; Weinreb I; Tong L; Xu W; Hope A
Oral Oncol; 2019 Oct; 97():124-130. PubMed ID: 31521053
[TBL] [Abstract][Full Text] [Related]
18. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
[TBL] [Abstract][Full Text] [Related]
20. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
